Burden of upper gastrointestinal symptoms in patients receiving low-dose acetylsalicylic acid for cardiovascular risk management: a prospective observational study
Research output: Contribution to journal › Journal article › Research › peer-review
Continuous low-dose acetylsalicylic acid (aspirin; ASA) is a mainstay of cardiovascular (CV) risk management. It is well established, however, that troublesome upper gastrointestinal (GI) symptoms are commonly experienced among low-dose ASA users.
| Original language | English |
|---|---|
| Journal | American Journal of Cardiovascular Drugs |
| Volume | 13 |
| Issue number | 1 |
| Pages (from-to) | 27-35 |
| Number of pages | 9 |
| ISSN | 1175-3277 |
| DOIs | |
| Publication status | Published - Feb 2013 |
ID: 47892408